Available October 6, 2026:

What remains when the cells are gone? Co-founders of Renatrix wash the cells out of food-grade organs and keep the answer, the extracellular matrix, the home the cells lived in, as a printable, tissue-specific gel. A 2040 where a doctor says four words instead of opening a waiting list: your tissue is ready.

Ahed Almalla learned chemistry in the seminar rooms and lecture halls of the University of Aleppo, until the war started and the journey led through Turkey to Germany. A master's in polymers and corrosion later, she walked into Marie Weinhart's group at FU Berlin in 2019 and picked the topic that sounded like fantasy: 3D printing organs and tissues instead of plastics and ceramics. When the PhD ended, she found a founders' program for women on LinkedIn, pitched, and met Komali Valishetti, a neuroscientist who had left the microscope because her curiosity kept asking a question her lab could not answer: who is going to use this? Almalla courted her for months. Valishetti took her time before saying yes.

The raw material is meat. A liver from the food supply chain is cut small, washed of blood, and decellularized. The cells leave, and what remains is a white scaffold: the ECM, the home the cells lived in, with the architecture intact. An enzyme breaks it into a honey-viscous gel that loads into a bioprinter as ink, carries 3D tissue models, or sets into membranes for wounds that today never close. The gel is tissue-specific, because a stomach cell and an intestinal cell need different homes (liver, intestine, pancreas and skin are in production), and every batch is made to be identical to the last, which is exactly what the field's workhorse material cannot promise.

Asked about 2040, Valishetti tells it as a story. A woman named Siri is living an ordinary life when her liver begins to fail. Her doctor does not talk donors or blood groups. A biopsy is taken, her own cells move into a printed scaffold and remodel it until it looks exactly like her own liver, candidate treatments are trialed on a personalized tissue model first. And then the sentence the whole episode is built around: your tissue is ready. Upstream, drugs that would have failed in humans die in the dish instead, and the animals they would have been tested on are never ordered.

Episode 2 of Grown, not Made.